Evaluation of a Porcine‐Derived Placental Powder Treatment for Skin Wound Healing in an In Vivo Rat Skin Defect Model
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2026-03 · 114 (3)
DOI: 10.1002/jbm.b.70047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, online erschienen am 26.02.2026. Verfasst von Alex Bryan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Herff College of Engineering, The University of Memphis, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Wound Healing, Skin, Placenta. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Convatec Triad Life Sciences Inc.
Themen: Wundversorgung
Abstract (Originalsprache)
Placental‐derived biomaterials are rising in popularity for use in treating severe skin injuries due to their abundant pro‐healing factors which result in improved healing outcomes. Clinical use of human‐derived placental products, however, is limited by high costs, donor availability, and high variability (due to age, health, and genetic factors). Porcine‐derived placental biomaterials have structure and pro‐healing factors similar to human placental materials, and can be mass produced on a larger scale, with reduced variability and cost. In this study, porcine‐derived placental biomaterials were compared to human‐derived placental biomaterials in a full‐thickness skin defect rat model. Porcine‐derived placental powder (PP), porcine‐derived placental membrane (PM), and human‐derived amniotic membrane (HM) were tested and compared to no treatment in 36 rats. At 3, 7, and 14 days, rats were euthanized, and defects were excised for H&E and picrosirius red staining. Analyses included wound area measurement, gross inflammation and histological inflammation scoring, qualitative assessments via H&E staining, and quantification of collagen in defects via picrosirius staining over the 14‐day healing process. No statistical differences were found between treatment groups at each timepoint for percent difference to adjacent control defect measurements including wound area, histological inflammation scoring, and collagen quantification analyses. PP treated defects had lower gross inflammation scores compared to HM at Day 3 ( p = 0.048). Trends observed in wound area measurements, gross and histological inflammation scores, and collagen quantification suggested that PP treated defects induced greater healing efficacy at earlier timepoints. Additionally, PP defects had more rapid and robust crust formation which may have contributed to improved healing outcomes based on reduced inflammation, improved hair follicle growth, re‐epithelialization, collagen formation, and protection during wound dressing changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Herff College of Engineering, The University of Memphis, Memphis, Tennessee, USA.
ORCID-Profile: Alex Bryan
Förderung
- Convatec Triad Life Sciences Inc
Zitieren
APA
Bryan, A., Atwill, M., Watson, A. B., Hall, S., Sadeghianmaryan, A., & Bumgardner, J. D. (2026). Evaluation of a Porcine‐Derived Placental Powder Treatment for Skin Wound Healing in an In Vivo Rat Skin Defect Model. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 114(3). https://doi.org/10.1002/jbm.b.70047
Vancouver
Bryan A, Atwill M, Watson AB, Hall S, Sadeghianmaryan A, Bumgardner JD. Evaluation of a Porcine‐Derived Placental Powder Treatment for Skin Wound Healing in an In Vivo Rat Skin Defect Model. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2026;114(3). doi:10.1002/jbm.b.70047
BibTeX
@article{Bryan2026,
author = {Bryan, Alex and Atwill, Matthew and Watson, Andrew Blass and Hall, Samantha and Sadeghianmaryan, Ali and Bumgardner, Joel D},
title = {Evaluation of a Porcine‐Derived Placental Powder Treatment for Skin Wound Healing in an In Vivo Rat Skin Defect Model},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2026},
volume = {114},
number = {3},
doi = {10.1002/jbm.b.70047}
}
EUVIMED